The company said there is potential likelihood that a serious anaphylactic reaction in patients, with known hypersensitivity to beta-lactam or penicillin products, could result from receiving these products.
To view a list of all products affected by this recall, click here (pdf).
There have been no reports of injuries reported to date, according to the release.
View the news release, hosted on the FDA website, about the recall by Aidapak Services.
Related Articles on Other Recent Recalls:
Boston Scientific Recalls iCross Coronary Catheters for Ultrasound Imaging
Beckman Coulter Recalls Ion Selective Electrolyte Flow Cell
Recalled Wipes Used at 25% of Veterans Affairs Medical Centers
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
